
Venlafaxine
Venlafaxine is an established SNRI antidepressant. Large network meta-analyses found it more effective than placebo for depression and generalized anxiety disorder, and trials support it for social anxiety disorder, though it had among the higher dropout rates. St. John's wort is the critical supplement interaction; alcohol, coffee and saffron are lesser concerns.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with major depression, generalized anxiety disorder, social anxiety disorder or panic disorder whose prescriber recommends an SNRI
Common dosing range
Set by your prescriber. The Effexor XR label recommends 75 mg once daily for most adults (sometimes starting at 37.5 mg for 4 to 7 days), up to a maximum of 225 mg per day
When to expect effects
Depression trials lasted a median of 8 weeks; in social anxiety trials venlafaxine beat placebo from week 1 to 6 onward
Watch out for
Boxed warning for suicidal thoughts and behaviors in young people. Never combine with MAO inhibitors or St. John's wort. Can raise blood pressure and bleeding risk. Do not stop suddenly: the label recommends a gradual reduction set by your prescriber
What is it
Venlafaxine is a prescription antidepressant of the serotonin and norepinephrine reuptake inhibitor (SNRI) class. It is sold as generic venlafaxine tablets and extended-release capsules and tablets, and under the brand name Effexor XR. The Effexor XR label approves it for adults with major depressive disorder, generalized anxiety disorder, social anxiety disorder and panic disorder. It is not approved for children.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
major depressive disorder Good Evidence | Modest; response odds about 1.4 to 2.1 times placebo across antidepressants | Adults with moderate to severe major depression without bipolar disorder | Acute trials lasted a median of 8 weeks |
generalized anxiety disorder Good Evidence | Modest; about 2.7 points more improvement on the Hamilton Anxiety Scale than placebo | Adult outpatients with generalized anxiety disorder | Measured at the end of the included randomized trials |
social anxiety disorder Good Evidence | Moderate; about 14 to 22 more responders per 100 people than placebo | Adults with generalized social anxiety disorder lasting 6 months or more | Separated from placebo between week 1 and week 6, depending on the trial |
major depressive disorder
- Effect
- Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
- Best fit
- Adults with moderate to severe major depression without bipolar disorder
- Time
- Acute trials lasted a median of 8 weeks
generalized anxiety disorder
- Effect
- Modest; about 2.7 points more improvement on the Hamilton Anxiety Scale than placebo
- Best fit
- Adult outpatients with generalized anxiety disorder
- Time
- Measured at the end of the included randomized trials
social anxiety disorder
- Effect
- Moderate; about 14 to 22 more responders per 100 people than placebo
- Best fit
- Adults with generalized social anxiety disorder lasting 6 months or more
- Time
- Separated from placebo between week 1 and week 6, depending on the trial
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
major depressive disorder
Disease adjunctA 2018 network meta-analysis of 522 double-blind trials with 116,477 adults found that all 21 antidepressants studied, including venlafaxine, were more effective than placebo for acute treatment of major depression, with odds ratios from 1.37 to 2.13. In head-to-head trials, venlafaxine was among the more effective drugs but also among those with the highest dropout rates. The authors rated the certainty of evidence moderate to very low overall. The median length of treatment in the trials was 8 weeks.
Bottom line: Venlafaxine works better than placebo for depression, with more dropouts than some alternatives.
generalized anxiety disorder
Disease adjunctA 2019 network meta-analysis of 89 randomized trials with 25,441 adult outpatients found venlafaxine more effective than placebo for generalized anxiety disorder, lowering the Hamilton Anxiety Scale score by 2.69 points more (95% credible interval 1.89 to 3.50), with relatively good acceptability. Duloxetine, pregabalin and escitalopram had similar effects.
Bottom line: Venlafaxine is one of several drugs that reliably ease generalized anxiety, by a modest margin.
social anxiety disorder
Disease adjunctIn a 12-week US trial of 440 adults with generalized social anxiety disorder, venlafaxine extended-release (75 to 225 mg per day) beat placebo from week 1 on the main anxiety scale, and 58.6% responded compared with 36.1% on placebo; paroxetine performed similarly (62.5%). A second 12-week trial of 271 adults found response in 44% versus 30% on placebo and remission in 20% versus 7%. Both trials lasted 12 weeks.
Bottom line: Venlafaxine helped about one more person in every 4 to 7 treated than placebo for social anxiety.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose; take it with food once a day and never stop suddenly on your own.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Suicidal thoughts and behaviors (boxed warning). Antidepressants increased these in children, teens and young adults in short-term studies; anyone taking venlafaxine should be watched for worsening mood, especially early and after dose changes.
Serotonin syndrome, especially with other serotonergic drugs (triptans, tramadol, amphetamines, St. John's wort) or MAO inhibitors.
Raised blood pressure, dose-related, including sustained high blood pressure and cases needing immediate treatment.
Higher risk of bleeding, from bruising and nosebleeds to life-threatening hemorrhage, greater with aspirin, NSAIDs, warfarin or other blood thinners.
Discontinuation syndrome after stopping or lowering the dose, which can be severe and long-lasting; the label recommends gradual tapering.
Low blood sodium (hyponatremia), more likely in older adults and people taking diuretics.
Angle-closure glaucoma in people with untreated narrow eye angles, seizures, activation of mania in people with bipolar disorder, and rare lung problems (interstitial lung disease, eosinophilic pneumonia).
Who should avoid it
- People taking an MAO inhibitor or within 14 days of stopping one (including linezolid or intravenous methylene blue); at least 7 days must pass after stopping venlafaxine before starting an MAOI
- People with known hypersensitivity to venlafaxine, desvenlafaxine or any ingredient in the product
- Children and teens: Effexor XR is not approved for pediatric patients, and the label says its safety and effectiveness in them have not been established
- People with uncontrolled high blood pressure, which the label says to control before starting
Pregnancy & breastfeeding
The Effexor XR label says studies of venlafaxine in pregnancy have not identified a drug-related risk of major birth defects or miscarriage. Use in mid to late pregnancy may increase the risk of preeclampsia, use in the month before delivery has been linked to a less than 2-fold higher risk of heavy bleeding after birth, and babies exposed late in pregnancy can have breathing, feeding or temperature problems after birth. Untreated depression also carries risks. Breastfeeding: venlafaxine and its active metabolite pass into breast milk (estimated relative infant dose 6.4 to 8.1% in two small studies) with no adverse reactions seen in those infants; the label says to weigh the benefits of breastfeeding against the mother's need for treatment.
Interactions
The Effexor XR label lists St. John's wort among serotonergic products that increase the risk of serotonin syndrome, a potentially life-threatening reaction, when combined with venlafaxine. Do not combine them without your prescriber's advice. Seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.
Contraindicated because of the risk of serotonin syndrome. The label requires at least 14 days after stopping an MAOI before starting venlafaxine, and at least 7 days after stopping venlafaxine before starting an MAOI.
The Effexor XR label says combining venlafaxine with tryptophan, the amino acid the body turns into serotonin, increases the risk of serotonin syndrome, a potentially life-threatening reaction. No case with this exact pair has been published. Do not add a tryptophan supplement unless your prescriber advises it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.
5-HTP is the body's direct building block for serotonin, so it adds to venlafaxine's serotonin effect. The Effexor XR label names tryptophan, the amino acid the body turns into 5-HTP, among products that increase the risk of serotonin syndrome; it does not name 5-HTP itself, and no venlafaxine case has been published. Do not combine them unless your prescriber directs it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.
The label says these drugs raise the risk of serotonin syndrome when taken with venlafaxine. Make sure every prescriber and your pharmacist know you take venlafaxine before a new medicine is added.
Drugs that affect serotonin reuptake, including venlafaxine, can increase bleeding, and the label says aspirin, NSAIDs, warfarin and other anticoagulants may add to this risk. People on warfarin need closer clotting tests when venlafaxine is started, changed or stopped. Ask your pharmacist before using an over-the-counter pain reliever.
The label advises avoiding alcohol while taking Effexor XR. In a study, steady-state venlafaxine did not worsen the effects of alcohol on thinking and coordination, but the risk of combining it with alcohol and other brain-active substances has not been systematically studied, and most venlafaxine overdoses have involved alcohol or other drugs. Be open with your prescriber about how much you drink.
Saffron extracts showed antidepressant effects in small trials, possibly partly through serotonin pathways, which raises a theoretical concern about added serotonergic effects with venlafaxine. The trials tested saffron alone or against antidepressants, not added to venlafaxine. Discuss it with your prescriber before using a saffron supplement.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (4)
+ 5-htp
criticalVenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Effexor XR label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with venlafaxine and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, an SSRI.
+ st. john's wort
criticalVenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). St. John's wort independently inhibits serotonin (and to a lesser extent norepinephrine and dopamine) reuptake. Combining them can drive synaptic serotonin higher and trigger serotonin syndrome, and the Effexor XR label lists St. John's Wort as a serotonin syndrome risk. St. John's wort also induces CYP3A4, one of the enzymes that clears venlafaxine, but whether it lowers venlafaxine levels has not been measured.
+ tryptophan
criticalVenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Effexor XR label says combining venlafaxine with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. No published case with this exact pair was found; the rating follows the label warning and matches the rating for tryptophan with SSRI antidepressants such as sertraline and fluoxetine, whose labels list it the same way.
+ alcohol
moderateVenlafaxine (Effexor) is an SNRI antidepressant, and alcohol is a central nervous system depressant. The FDA-approved label advises avoiding alcohol because the combination can add to drowsiness and dizziness and can worsen the mood or anxiety disorder being treated. The concern is about additive sedation, blood pressure, and undermined treatment rather than a dramatic pharmacokinetic clash, which is why it is rated moderate.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take St. John's wort with venlafaxine?⌄
This page rates it a critical interaction. The Effexor XR label lists St. John's wort among products that raise the risk of serotonin syndrome with venlafaxine. Talk to your prescriber before using it, and if you have been combining them, contact your prescriber rather than stopping anything on your own.
Can I drink coffee on venlafaxine?⌄
Venlafaxine does not slow how your body clears caffeine; in a study of 16 healthy adults, caffeine levels were unchanged. Caffeine can still add to nervousness and trouble sleeping, which venlafaxine can also cause, so review your intake with your doctor or pharmacist if you notice these.
Can I drink alcohol while taking venlafaxine?⌄
The label advises avoiding alcohol during treatment. The risk of combining venlafaxine with alcohol has not been systematically studied, and alcohol can make depression and anxiety harder to treat. Be honest with your prescriber about your drinking.
Is saffron safe with venlafaxine?⌄
The concern is theoretical: saffron may act partly on serotonin, but it has not been studied added to venlafaxine. This page rates the pair low severity. Ask your prescriber before starting a saffron supplement.
What happens if I stop venlafaxine suddenly?⌄
Stopping suddenly or lowering the dose can cause discontinuation symptoms such as dizziness, irritability, nausea and anxiety, which can be severe. The label recommends a gradual reduction, sometimes over months. Talk to your prescriber before making any change.
Does venlafaxine raise blood pressure?⌄
It can. Trials showed dose-related increases in blood pressure, including sustained high blood pressure, so the label advises checking blood pressure before starting and regularly during treatment.
References by claim
major depressive disorder
Cipriani et al., 2018 · PMC (2018) link
generalized anxiety disorder
Slee et al., 2019 · PubMed (2019) link
social anxiety disorder
Safety
Effexor XR (venlafaxine extended-release capsules) prescribing information · DailyMed (FDA label) link
Interaction: Saffron (supplements)
Lopresti et al., 2014 · PubMed (2014) link
Interaction: 5-HTP (5-hydroxytryptophan)
Patel et al., 2017 · PMC (2017) link
Track Venlafaxine with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
